arm_1
1 clinical trial
1 product
1 indication
Clinical trial
A Phase I Study of the Safety, Pharmacokinetic and Pharmacodynamic Properties of Orally Administered APG-2449 in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2025-01-01
Product
APG-2449Indication
NSCLC, mesothelioma, or ovarian cancer